Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Ketogenic diet ameliorates attention deficit hyperactivity disorder in rats via regulating gut microbiota

PROVIDER: PRJNA991258 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25131607_1.fastq.gz	Fastqsanger.gz
	SRR25131607_2.fastq.gz	Fastqsanger.gz
	SRR25131608_1.fastq.gz	Fastqsanger.gz
	SRR25131608_2.fastq.gz	Fastqsanger.gz
	SRR25131609_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 120

Similar Datasets

Genetic Investigations of Attention-Deficit/Hyperactivity Disorder

Project description:Genetic Investigations of Attention-Deficit/Hyperactivity Disorder

| PRJNA1114309 | ENA

Genetic Investigations of Attention-Deficit/Hyperactivity Disorder

Project description:Genetic Investigations of Attention-Deficit/Hyperactivity Disorder

| PRJNA1114310 | ENA

Homo sapiens

Project description:Genetic studies of Attention-Deficit/Hyperactivity Disorder

| PRJNA1011341 | ENA

Project description:Attention Deficit Hyperactivity Disorder and the Gut Microbiome

| PRJNA656791 | ENA

Gene expression correlated with inattention and hyperactivity/impulsivity rating scales in Tourette syndrome

Project description:Inattention, impulsivity and hyperactivity are the primary behaviors associated with Attention Deficit / Hyperactivity Disorder (ADHD). Previous studies proved that peripheral blood gene expression signature could mirror central nervous system disease. This study determined if gene expression in blood correlated with inattention, hyperactivity/impulsivity rating scales and/or both in subjects with Tourette syndrome (TS).

2014-06-30 | GSE30470 | GEO

Project description:New gene for dominant combined attention deficit/hyperactivity disorder and delayed sleep phased disorder

| PRJNA624188 | ENA

CFTR acts as a potential therapeutic target for attention deficit-hyperactivity disorder

Project description:CFTR acts as a potential therapeutic target for attention deficit-hyperactivity disorder

| PRJNA1197996 | ENA

Effect of methylphenidate on gene expression profiles of Attention Deficit Hyperactivity Disorder patients and unaffected controls.

Project description:Attention deficit hyperactivity disorder (ADHD) is a common psychiatric condition of children with a prevalence of 5-10% worldwide. Up to 30% of adults with a history of childhood ADHD maintain symptoms in later life; these adult ADHD patients are severely impaired in social and professional life due to persistence of ADHD core symptoms like impulsivity, attention deficit and hyperactivity as well as frequently observed co-morbidities like alcohol and drug abuse, major depression, bipolar and personality disorders. Pharmaceutical treatment options include methylphenidate (MPH), which is amongst others an inhibitor of the dopamine transporter and therefore increases dopamine levels in the brain. However, not all ADHD patients are MPH responders with clinical features to distinguish responders and non-responders being not at hand so far. Likewise, neurobiological reasons for drug response are still elusive. Here, we examined the global transcriptional response of MPH on lymphoblastoid cell lines (LCLs) derived from ADHD patients and unaffected controls.

2014-09-05 | E-GEOD-52889 | biostudies-arrayexpress

Gut microbiota of children

Project description:Children with Attention-Deficit Hyperactivity Disorder or Autism spectrum disorder have distinct and shared microbiota compositions

| PRJNA701402 | ENA

Project description:Gut microbiota and clinical manifestations in Thai pediatric patients with attention deficit hyperactivity disorder

| PRJNA988940 | ENA